Zi-Jie Song, Xiao-Fei Wu, Zhi-Ya Zhou, Jing-Jing Zhang, P.A.N. Yan-Yan, Xue Dong, Xuan Pang, Ya-Ping Xie, Juan Sun, Yu Zhang, Jie Qin
{"title":"Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents","authors":"Zi-Jie Song, Xiao-Fei Wu, Zhi-Ya Zhou, Jing-Jing Zhang, P.A.N. Yan-Yan, Xue Dong, Xuan Pang, Ya-Ping Xie, Juan Sun, Yu Zhang, Jie Qin","doi":"10.1016/j.ejmech.2025.117286","DOIUrl":null,"url":null,"abstract":"A library comprising twenty-four isosteric derivatives of celecoxib substituted with carboxylic acid (labeled as <strong>5a</strong>-<strong>5x</strong>), was synthesized and characterized through <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and elemental analysis. Molecular docking studies revealed that all compounds successfully docked into the binding pocket of COX-2, and the introduction of carboxyl group enhances the interaction between the derivatives and COX-2. The compounds were further evaluated for cell toxicity, and <em>in vitro</em> anti-inflammatory activity. Notably, compound <strong>5l</strong> exhibited significant inhibition of both COX-2 and NO release <em>in vitro</em> in comparison to the standard compound, displaying the highest selectivity towards the COX-2 enzyme (SI = 295.9) in comparison to celecoxib (SI = 261.3). <strong>5l</strong> also exhibited the most potent anti-inflammatory activity and safety (ulcer index = 5.2) <em>in vivo</em> comparable to celecoxib at the same concentration. Through the molecular modeling and dynamics analysis, it was observed that compound <strong>5l</strong> effectively stabilized within the active binding site of COX-2 through strong hydrogen bond interactions, and through the ADMET studies investigated the physiochemical properties and drug-likeliness behavior of compound <strong>5l</strong>. In conclusion, compound <strong>5l</strong> demonstrated to be a potential selective COX-2 anti-inflammatory candidate with reduced gastrointestinal risks.","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"83 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejmech.2025.117286","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
A library comprising twenty-four isosteric derivatives of celecoxib substituted with carboxylic acid (labeled as 5a-5x), was synthesized and characterized through 1H NMR, 13C NMR, HRMS, and elemental analysis. Molecular docking studies revealed that all compounds successfully docked into the binding pocket of COX-2, and the introduction of carboxyl group enhances the interaction between the derivatives and COX-2. The compounds were further evaluated for cell toxicity, and in vitro anti-inflammatory activity. Notably, compound 5l exhibited significant inhibition of both COX-2 and NO release in vitro in comparison to the standard compound, displaying the highest selectivity towards the COX-2 enzyme (SI = 295.9) in comparison to celecoxib (SI = 261.3). 5l also exhibited the most potent anti-inflammatory activity and safety (ulcer index = 5.2) in vivo comparable to celecoxib at the same concentration. Through the molecular modeling and dynamics analysis, it was observed that compound 5l effectively stabilized within the active binding site of COX-2 through strong hydrogen bond interactions, and through the ADMET studies investigated the physiochemical properties and drug-likeliness behavior of compound 5l. In conclusion, compound 5l demonstrated to be a potential selective COX-2 anti-inflammatory candidate with reduced gastrointestinal risks.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.